New treatment for herpes simplex virus type 2 [ultrasound and zinc, urea, and tannic acid ointment]. Part I--Male patients.
Twenty-three male patients with herpes simplex virus type 2 blisters on the prepuce, glans penis, and penile shaft were divided into two groups. Ten patients served as controls, and thirteen patients were treated with ultrasound (1 watt/cm2 for 60 seconds) and Herpigon on three consecutive days. Results showed a negative virus culture after three days of treatment and significant reduction of recurrent infection in the treated group while the control group experienced recurrent infection within 62-80 days. This method offers a new therapeutic treatment for genital herpes simplex virus.
D000328:Adult; D000818:Animals; D006168:Guinea Pigs; D006561:Herpes Simplex / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D047348:Hydrolyzable Tannins / Q000008:administration & dosage* / Q000627:therapeutic use; D008297:Male; D009824:Ointments; D013634:Tannins / Q000008:administration & dosage*; D014464:Ultrasonic Therapy; D014508:Urea / Q000008:administration & dosage* / Q000627:therapeutic use; D015032:Zinc / Q000008:administration & dosage* / Q000627:therapeutic use
D047348:Hydrolyzable Tannins; D009824:Ointments; D013634:Tannins; D014508:Urea; D015032:Zinc